2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Top Cited Papers
Open Access
- 31 March 2023
- journal article
- review article
- Published by Korean Liver Cancer Association in Journal of Liver Cancer
- Vol. 23 (1) , 1-120
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the clinical management of patients with HCC. A total of 49 experts in the fields of hepatology, oncology, surgery, radiology, and radiation oncology from the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions. These guidelines provide useful information and direction for all clinicians, trainees, and researchers in the diagnosis and treatment of HCC.Keywords
This publication has 1016 references indexed in Scilit:
- Hepatocellular carcinoma with extrahepatic metastasisCancer, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicitiesHepatology, 2010
- Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort studyHepatology, 2010
- Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies #Hepatology, 2009
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Risk factors for intrahepatic recurrence in human small hepatocellular carcinomaGastroenterology, 1995